Patents Assigned to SONNET BIO THERAPEUTICS
  • Albumin binding domain fusion proteins
    Patent number: 11028166
    Abstract: Compositions that include an albumin binding domain and a fusion partner (e.g., a cytokine or a binding moiety) are provided. Such therapeutics have increased serum half-life and find use in applications where one or more such therapeutics are needed, for example, in oncology applications.
    Type: Grant
    Filed: February 20, 2018
    Date of Patent: June 8, 2021
    Assignee: SONNET BIO THERAPEUTICS
    Inventors: John K. Cini, Haomin Huang